Health Trials

Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic Neuralgia

ConditionPost Herpetic Neuralgia (PHN)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-65
SponsorMohamed Hosny Ismail Easa

About this trial

The purpose of this study is to evaluate the therapeutic efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) in the treatment of patients with post-herpetic neuralgia (PHN). Participants will receive taVNS in addition to standard care. The study aims to determine whether taVNS can provide significant pain relief and improve quality of life in PHN patients.

Eligibility criteria

Qualifiers

None

Disqualifiers

pregnancy;

active implants (e.g., pacemakers, cochlear implants) or brain shunts;

previous neurological or psychiatric diagnoses;

history of addiction or substance abuse;

Trial design

Treatments tested in this trial

  • transcutaneous auricular vagus nerve stimulation (taVNS)
  • traditional medical treatment for PHN

Treatment groups

34 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Faculty of Physical Therapy - Cairo UniversityRecruiting12613, Cairo, Giza GovernorateEgyptEgypt

Sponsors and collaborators

Mohamed Hosny Ismail Easa

Lead sponsor

Cairo University

Sponsor institution

Source ClinicalTrials.gov